(Bloomberg) -- Follow Bloomberg on LINE messenger for all the business news and analysis you need.
Singapore’s embattled water treatment firm Hyflux Ltd. has received interest from a new investor, a day before its next court hearing, adding yet another twist to the nation’s most high-profile debt restructuring case that has dragged for more than 18 months.
Hyflux received a letter from Longview International Holdings expressing interest in investing in the company together with an undisclosed “major Chinese entity” as a joint venture partner, according to a filing.
The statement didn’t provide any further details on the plan. The new bid comes even as Hyflux investors are assessing two other offers, one of which seeks only to buy the company’s debt and the other most of its equity.
Singapore-based Longview was incorporated in August 2016 and is into management consultancy services, information from the Accounting and Corporate Regulatory Authority shows. It also counts research and experimental development on biotechnology, life and medical science among its business. It has a paid-up share capital of S$6 million and lists Chinese national Song Yupeng, Taiwan citizen Yang Hung-Yi and Singaporean Cheong Pin Seng among its directors.
The delays in the high profile restructuring has frustrated investors. Hyflux’s collapse has left some 34,000 retail investors in the lurch. Middle Eastern suitor Utico FZC, which reached a deal with Hyflux in November to invest a total of S$400 million, still awaits investor approvals. The entry of mystery bidder Aqua Munda Pte, which in December offered to buy up the company’s debt, has prompted further uncertainty for the company’s investors. Last month, Hyflux’s debt moratorium was extended until Feb. 28.
The hearing tomorrow is another in the series of many since a court-supervised process started in May 2018.
©2020 Bloomberg L.P.
RECOMMENDED FOR YOU
POPULAR